- Home
- CDTX vs ENLT Comparison
CDTX vs ENLT Comparison
Compare CDTX & ENLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- ENLT
- Stock Information
- Founded
- CDTX 2012
- ENLT 2008
- Country
- CDTX United States
- ENLT Israel
- Employees
- CDTX N/A
- ENLT N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- ENLT
- Sector
- CDTX Health Care
- ENLT
- Exchange
- CDTX Nasdaq
- ENLT Nasdaq
- Market Cap
- CDTX 2.8B
- ENLT 2.9B
- IPO Year
- CDTX 2015
- ENLT 2023
- Fundamental
- Price
- CDTX $109.03
- ENLT $34.61
- Analyst Decision
- CDTX Strong Buy
- ENLT Hold
- Analyst Count
- CDTX 13
- ENLT 4
- Target Price
- CDTX $118.50
- ENLT $28.50
- AVG Volume (30 Days)
- CDTX 986.8K
- ENLT 31.3K
- Earning Date
- CDTX 11-06-2025
- ENLT 11-12-2025
- Dividend Yield
- CDTX N/A
- ENLT N/A
- EPS Growth
- CDTX N/A
- ENLT N/A
- EPS
- CDTX N/A
- ENLT 0.17
- Revenue
- CDTX N/A
- ENLT $428,715,000.00
- Revenue This Year
- CDTX N/A
- ENLT $355.90
- Revenue Next Year
- CDTX N/A
- ENLT $42.83
- P/E Ratio
- CDTX N/A
- ENLT $40.70
- Revenue Growth
- CDTX N/A
- ENLT 39.54
- 52 Week Low
- CDTX $12.54
- ENLT $14.01
- 52 Week High
- CDTX $121.21
- ENLT $36.65
- Technical
- Relative Strength Index (RSI)
- CDTX 57.26
- ENLT 63.27
- Support Level
- CDTX $93.60
- ENLT $34.47
- Resistance Level
- CDTX $107.00
- ENLT $36.01
- Average True Range (ATR)
- CDTX 5.83
- ENLT 0.79
- MACD
- CDTX -1.38
- ENLT -0.09
- Stochastic Oscillator
- CDTX 39.96
- ENLT 55.13
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About ENLT Enlight Renewable Energy Ltd.
Enlight Renewable Energy Ltd develops, finances, constructs, owns, and operates utility-scale renewable energy projects. The company's operating segments are the MENA segment, Europe segment, U.S.A segment, and Others. It generates the majority of its revenue from the Europe segment, which produces its revenue from the sale of the electricity that is produced through wind energy and solar energy in Europe.